| abstract |
The present invention belongs to the field of pneumococcal capsular saccharide conjugate vaccine. Specifically the present invention provides immunogenic composition which is used for infant and comprises multivalent Streptococcus pneumoniae conjugate vaccine. The multivalent Streptococcus pneumoniae conjugate vaccine comprises two or more conjugated capsular saccharides from different serological type. The vaccine can be used for infant group for reducing the sickness rate of pneumococcal disease, such as COPD deterioration and/or IPD. |